Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06013449 · ClinicalTrials.gov registry record · NA
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations
A NA study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06013449 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.
The verdict
NCT06013449, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to test the idea that Pulsed Electromagnetic Field (PEMF) therapy will serve as a safe therapeutic modality that can effectively be administered simultaneously with bladder instillations of a bupivacaine-heparin cocktail to improve the chronic pain and/or associated symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) patients. The study team will distribute the PEMF device to female adults with IC/BPS who have been prescribed bladder instillations of bupivacaine-heparin to see if PEMF therapy in conjunction with bladder instillations of heparin and bupivacaine may be more effective in reducing pain levels and symptomatology of IC/BPS than instillations alone.
Interventions
- DEVICE Pulsed Electromagnetic Field (PEMF) Device
- DEVICE Sham Pulsed Electromagnetic Feild (PEMF) Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06013449
The ClinicalTrials.gov registry entry for NCT06013449 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pulsed Electromagnetic Field (PEMF) Device is the first listed.
NCT06013449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06013449 about?
NCT06013449 is a clinical study titled "Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations". The objective of this study is to test the idea that Pulsed Electromagnetic Field (PEMF) therapy will serve as a safe therapeutic modality that can effectively be administered simultaneously with bladder instillations of a bupivacaine-heparin cocktail to improve the chronic pain and/or associated sy...
What is the current status of trial NCT06013449?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-09. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06013449?
The interventions under investigation include: Pulsed Electromagnetic Field (PEMF) Device (DEVICE), Sham Pulsed Electromagnetic Feild (PEMF) Device (DEVICE).
Who is sponsoring clinical trial NCT06013449?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.